KNIGHT CAPITOL CONSULTANTS for SANOFI US SERVICES INC (FORMERLY KNOWN AS "SANOFI-AVENTIS U S INC )
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Torts TOR
Possible changes to the Vaccine Injury Compensation Program (no legislation yet)
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so, too, Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | (Previously listed) |
Taxation/Internal Revenue Code TAX
Extension of Research and Development Tax Credit (P.L. 111-142), Tax Extenders Legislation (P.L. 111-312) and such provisions included in "The American Research and Competitiveness Act of 2011" (H.R. 942), and the "Greater Research Opportunities with Tax Help Act" (S. 1577).
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so, too, Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Previously Listed |
Copyright/Patent/Trademark CPT
Legislation regulating agreements between pharmaceutical companies to settle patent infringement lawsuits (S. 27 and deliberations of Deficit Reduction Committee).
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so, too, Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | Professional Staff, House Approps Cmte |
Health Issues HCR
Pharmaceutical industry issues, including: implementation of, changes to, or repeal of all or parts of the Patient Protection and Affordable Care Act (PL 111-148)/Health Care and Education Reconciliation Act of 2010 (PL 111-152) including the Independent Payment Advisory Board; reimbursement in Medicare Parts B and D; access to diabetes care and atrial fibrillation care, including H.Res. 295, and S. Res. 243; and importation of prescription drugs, amendment 769 to H.R. 2112, Continuing Appropriations.
Foreign entity interest: sanofi-aventis U.S. Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit sanofi-aventis U.S. Inc., so, too, Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| PATRICIA KNIGHT | previously listed |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| SANOFI SA | France | France | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.